Lower Limb Immobilisation VTE Risk
Interactive lower limb immobilisation VTE assessment with progressive reveal, clipboard summary, and print / PDF export.
This tool is provided for clinical support and documentation assistance. Final clinical decisions remain the responsibility of the treating clinician.
Live
Related documents
Feedback
Report issues with this proforma. Do not include patient identifiers.
Potential high-risk immobilisation
| Expected rigid / non-weight-bearing immobilisation for 7 days or more | |
|---|---|
| Local high-risk injuries:Achilles | |
Patient-specific risk factors
| Age |
Years
|
|---|---|
| Sex genetic | |
| Height |
|
| Weight (booking weight if pregnant) |
|
| BMI |
kg/m²
|
| Pregnant | |
| <6 weeks post-partum | |
| Immobilisation typeSelect recommended immobilisation category (i.e. from eTrauma/vFC) | |
| Patient-specific risk factors | |
| Family history of VTE (1st degree relative) | |
| Personal history of VTE / known thrombophilia | |
| Combined oral contraceptive / oestrogen HRT Oral/Depot Oestrogen or Oestrogen Receptor Modulators (Tamoxifen, Raloxifene, Clomiphene) | |
| Cancer diagnosis within past 5 years | |
| Immobilisation within past 3 months (hospital admission, bedridden, flight >6h, lower limb paralysis) | |
| Surgery within past 3 months | |
| PMHx of one/more of heart failure, rheumatoid arthritis, CKD, COPD, inflammatory bowel disease | |
| Varicose veins | |
Specific injury categories
| Low-risk |
|
|---|---|
| Intermediate-risk |
|
| High-risk |
|
Thromboprophylaxis contraindications
| Contraindications | |
|---|---|
| Active bleeding / peptic ulcer / bleeding disorder | |
| Already taking anticoagulation | |
| Platelets < 30 (30-50 d/w Haematology) | |
| Cerebral haemorrhage < 7 days ago | |
| Ischaemic stroke < 14 days ago | |
| Uncontrolled hypertension (>180/120 on repeat recommended assessment) | |
| Any brain / spine / eye / ear / cardiothoracic surgery / TAVR in last 2 weeks | |
| Acute bacterial endocarditis | |
| Known Creatinine Clearance (CrCl) < 15 | |
| Creatinine | µmol/L |
| Calculated Creatinine Clearance | mL/min |
Concern for non-acute renal / platelet deterioration requiring bloods?
Apixaban
| Hypersensitivity | |
|---|---|
| Pregnancy / Breastfeeding | |
| Known liver disease with coagulopathy | |
| 2+ drug interaction classes |
|
| Antiphospholipid syndrome | |
Apixaban 2.5mg BD for 2 weeks recommended.
Enoxaparin contraindications
| Contraindications | |
|---|---|
| Hypersensitivity | |
| Previous HIT (Heparin-induced thrombocytopenia) | |
Summary
View a formatted clinical summary or copy a plain-text version for pasting into the clinical record.
Live pathway status
TRIP(cast) score: 1
Current stepAwaiting pathway entry questions
Derived values
BMI: —
BSA: —
CrCl: —
Summary copied to clipboard.